Portfolio

What will it take to defeat Alzheimer’s disease?

Project specs

Format

Category

Health & Medicine

Client

University of Kentucky

Contact

Mark T.W. Ebbert

Country

United States

Funding agency

National Institute on Aging (NIH), National Institute of General Medical Sciences, BrightFocus Foundation, Alzheimer’s Association, PhRMA Foundation

Length

1.5

Summary

Alzheimer’s disease (AD) is currently incurable due to ineffective treatments and late diagnoses. Ground-breaking research led by Prof. Ebbert at the University of Kentucky’s Sanders-Brown Center on Aging offers hope. Using cutting-edge technology to study RNA in the brain, the Ebbert Lab is working to develop personalized therapies and a pre-symptomatic disease diagnostic, potentially revolutionizing the treatment of AD and other incurable diseases.